Oct. 23 at 1:10 PM
$MBRX Reuters 24 minutes ago
Oct 23 (Reuters) - Moleculin Biotech Inc (MBRX.NaE):
* MOLECULIN ANNOUNCES NEW INVESTIGATOR-INITIATED STUDY OF ANNAMYCIN FOR TREATING PANCREATIC CANCER
* MOLECULIN BIOTECH INC (MBRX.NaE) - ESTIMATES TRIAL COST AT
$1.X MILLION FROM 2026 TO 2030 Source text: Further company coverage: